Company Panacea Global Inc OTC Bulletin Board
Equities
US6981031080
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yuri Lawryshyn
CEO | Chief Executive Officer | 58 | 16-06-16 |
David Sohi
DFI | Director of Finance/CFO | - | 16-06-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yuri Lawryshyn
CEO | Chief Executive Officer | 58 | 16-06-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 106,747,586 | 24,747,586 ( 23.18 %) | 0 | 23.18 % |
Company contact information
Panacea Global, Inc.
330 Highway 7 East Suite 502
L4B 3P8, Richmond Hill
+
Sector
1st Jan change | Capi. | |
---|---|---|
+46.71% | 56.61B | |
-7.87% | 39.62B | |
+35.91% | 39.25B | |
-6.90% | 28.28B | |
+10.79% | 26.44B | |
-16.63% | 20.12B | |
+29.35% | 12.51B | |
+29.74% | 12.48B | |
-0.32% | 12.2B |
- Stock Market
- Equities
- PANG Stock
- Stock
- Company Panacea Global Inc